This funding opportunity promotes the discovery and early evaluation of candidate biomarkers and biomarker signatures for neurological and neuromuscular disorders. It supports research including animal studies but requires preliminary human evaluation using standardized samples or datasets. The goal is to develop biomarkers ready for definitive analytical and clinical validation studies to facilitate neurotherapeutic development and clinical use.
Eligible applicants include a wide range of U.S. entities such as government bodies, higher education institutions, nonprofits, for-profit organizations, small businesses, and Native American tribal governments. Specific eligibility details should be confirmed in the full announcement.
